Immediate Impact
57 standout
Citing Papers
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial
2024 Standout
Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models
2023 Standout
Works of Mark Wildgust being referenced
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
2013
Cardiac Safety of Pegylated Liposomal Doxorubicin (Doxil®/Caelyx®) Demonstrated by Endomyocardial Biopsy in Patients with Advanced Malignancies
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark Wildgust | 343 | 154 | 339 | 179 | 18 | 570 | |
| Q.H. Le | 158 | 77 | 309 | 168 | 14 | 596 | |
| Valentina Carrai | 217 | 129 | 218 | 62 | 26 | 458 | |
| Saburo Tsunoda | 161 | 121 | 233 | 177 | 27 | 565 | |
| Adolfo Porcellini | 192 | 333 | 96 | 283 | 16 | 500 | |
| Angela Volkert | 308 | 62 | 360 | 119 | 16 | 470 | |
| Paola R. Lev | 269 | 75 | 347 | 81 | 31 | 641 | |
| Marion Montastruc | 190 | 51 | 275 | 148 | 30 | 534 | |
| Matthew J. Wong | 182 | 53 | 225 | 125 | 12 | 587 | |
| Michael H. Brave | 124 | 29 | 173 | 361 | 15 | 645 | |
| Gerlinde Mitterbauer‐Hohendanner | 211 | 60 | 320 | 97 | 20 | 516 |
All Works
Loading papers...